-Reuters
Related Posts
Co-Diagnostics, Inc. Initiates Clinical Evaluations For Its At-Home And Point-Of-Care Co-Dx PCR Home Platform
Co-Diagnostics, Inc. (NASDAQ:CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced
Jim Cramer Says Facebook-Parent Meta Has Become Undervalued But Here’s Why You Should Wait Further To Buy
CNBC host Jim Cramer said investors wanting to buy Meta Platforms Inc. (NASDAQ: FB) stock should wait for the stock to find a bottom as institutional selling is extensive.
ICER’s Report Suggests Benefits Of Eli Lilly’s Tirzepatide Not Better Than Other Diabetes Drugs
Institute for Clinical and Economic Review (ICER) casts doubts on Eli Lilly And Co’s (NYSE: LLY) tirzepatide, a type II diabetes candidate, about its usefulness to patients compared to the rivals.